Taken together, based on the inhibitions of AML cell viability, colonies formed and PD-L1 expression, and increased phagocytosis, we anticipate that MeTC7 can improve the survival in AML via inhibition of PD-L1. This evidence concerns the gene CD274 and acute myeloid leukemia.